Elezanumab, a Clinical Stage Human Monoclonal Antibody That Selectively Targets Repulsive Guidance Molecule A to Promote Neuroregeneration and Neuroprotection in Neuronal Injury and Demyelination Models.
Neurobiology of Disease（2021）
关键词
RGMa,Elezanumab,ABT-555,ABT-207,Monoclonal antibody,BMP,Neuroregeneration,Neuroprotection,Optic nerve crush,Optic neuritis,Targeted EAE,Demyelination,Remyelination
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要